G. Cianciolo et al., Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes, NEPH DIAL T, 16(6), 2001, pp. 1222-1229
Background, During haemodialysis the blood-membrane contact causes a releas
e of platelet granule content, which contains platelet-derived growth facto
r AB (PDCF-AB). In view of the potential role of this in altering biocompat
ibility during haemodialysis, we evaluated the intra- and post-dialytic cha
nges in PDGF-AB serum levels during haemodialysis sessions performed with c
ellulose diacetate (CDA) and polysulfone (PS) membranes respectively.
Methods. PDGF-ABI platelet factor 4 (PF4), beta thromboglobulin (beta TG),
and mean platelet volume (MPV) levels were determined in 30 patients, each
of whom underwent six dialysis sessions: three with a CDA and three with a
PS membrane. Blood samples were taken at times 0, 15, 30, 120, 180, and 240
min during dialysis and at 1, 4, and 20 h after the end of the session. St
atistical analysis was performed using a one-way ANOVA and Student's t test
.
Results. PDGF-AB at 15 min was increased to +41 +/- 9% with CDA vs + 20 +/-
5% with PS (P< 0.001) from the TO values, and at 120 min it was + 19 +/- 8
'%, with CDA vs -25 +/- 9% with PS (P < 0.001) from TO levels. At 240 min i
t was +95+/-14% with CDA vs +49+/-15% with PS (P<0.001) from the TO values,
returning to basal only 20 h after the end of the session. <beta>TG at 15
min was + 60 +/- 8% for CDA vs + 24 +/- 7.5% for PS (P < 0.001) from the T0
values. PF4 showed a similar trend to <beta>TG. MPV at 30 min from the sta
rt of dialysis was 7.4 +/- 0.3 fl with CDA and 8 +/- 0.3 fl with PS (P<0.00
1), and at 240 min MPV was 7.9+/-0.3 fl with CDA and 8.4+/-0.3 fl with PS (
P < 0.001).
Conclusions. Platelet activation and platelet release reactions are lower w
ith PS than with CDA membranes. PDGF-AB, released during and after dialysis
, represents a clear biocompatibility marker. Its slow return to basal valu
es and its action on vascular cells make it a potential risk factor for ath
erosclerosis in uraemic patients.